This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Christophe Lm Verlinde: Innovator in Methionyl-tRNA Synthetase Inhibition
Introduction
Christophe Lm Verlinde is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biochemistry, particularly in the area of methionyl-tRNA synthetase (MetRS) inhibition. His work has implications for treating various diseases that can be ameliorated through this inhibition.
Latest Patents
Christophe Lm Verlinde holds 1 patent for his invention titled "Specific inhibitors of methionyl-tRNA synthetase." This patent focuses on compositions that are useful in inhibiting MetRS and outlines methods for treating diseases that benefit from this inhibition.
Career Highlights
He is affiliated with the University of Washington, where he conducts research and develops innovative solutions in his field. His work has garnered attention for its potential applications in medical treatments.
Collaborations
Christophe has collaborated with esteemed colleagues, including Frederick Simmons Buckner and Ximena Barros Alvarez. These partnerships have enhanced the scope and impact of his research.
Conclusion
Christophe Lm Verlinde is a prominent figure in the realm of biochemistry, with a focus on methionyl-tRNA synthetase inhibition. His contributions are paving the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile